Next Article in Journal
Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer
Next Article in Special Issue
Molecular In-Depth Characterization of Chondrosarcoma for Current and Future Targeted Therapies
Previous Article in Journal
Obinutuzumab, High-Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients with Richter’s Syndrome
Previous Article in Special Issue
Changes of Protein Expression after CRISPR/Cas9 Knockout of miRNA-142 in Cell Lines Derived from Diffuse Large B-Cell Lymphoma
 
 
Article

Article Versions Notes

Cancers 2022, 14(24), 6036; https://doi.org/10.3390/cancers14246036
Action Date Notes Link
article xml file uploaded 8 December 2022 05:49 CET Original file -
article xml uploaded. 8 December 2022 05:49 CET Update https://www.mdpi.com/2072-6694/14/24/6036/xml
article pdf uploaded. 8 December 2022 05:49 CET Version of Record https://www.mdpi.com/2072-6694/14/24/6036/pdf
article supplementary file uploaded. 8 December 2022 05:49 CET - https://www.mdpi.com/2072-6694/14/24/6036#supplementary
article html file updated 8 December 2022 05:50 CET Original file -
article html file updated 1 March 2023 03:06 CET Update -
article html file updated 4 March 2023 02:06 CET Update https://www.mdpi.com/2072-6694/14/24/6036/html
Back to TopTop